141 related articles for article (PubMed ID: 15724352)
1. Efficacy of tacrolimus ointment in the prevention and treatment of contact dermatitis.
Anderson BE; Marks JG; Mauger DT
Dermatitis; 2004 Sep; 15(3):158-9. PubMed ID: 15724352
[No Abstract] [Full Text] [Related]
2. Prevention of sodium lauryl sulfate irritant contact dermatitis by Pro-Q aerosol foam skin protectant.
Patterson SE; Williams JV; Marks JG
J Am Acad Dermatol; 1999 May; 40(5 Pt 1):783-5. PubMed ID: 10321615
[TBL] [Abstract][Full Text] [Related]
3. Putative skin-protective formulations in preventing and/or inhibiting experimentally-produced irritant and allergic contact dermatitis.
Zhai H; Willard P; Maibach HI
Contact Dermatitis; 1999 Oct; 41(4):190-2. PubMed ID: 10515096
[TBL] [Abstract][Full Text] [Related]
4. The effect of topically applied corticosteroid on irritant and allergic patch test reactions.
Green C
Contact Dermatitis; 1996 Dec; 35(6):331-3. PubMed ID: 9118626
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus ointment in nickel sulphate-induced steroid-resistant allergic contact dermatitis.
Pacor ML; Di Lorenzo G; Martinelli N; Mansueto P; Friso S; Pellitteri ME; Di Fede G; Rini G; Corrocher R
Allergy Asthma Proc; 2006; 27(6):527-31. PubMed ID: 17176790
[TBL] [Abstract][Full Text] [Related]
6. Prevention of surfactant-induced irritant contact dermatitis.
Wilhelm KP
Curr Probl Dermatol; 1996; 25():78-85. PubMed ID: 8787591
[No Abstract] [Full Text] [Related]
7. Tacrolimus ointment 0.1% in the treatment of allergic contact eyelid dermatitis.
Katsarou A; Armenaka M; Vosynioti V; Lagogianni E; Kalogeromitros D; Katsambas A
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):382-7. PubMed ID: 19207676
[TBL] [Abstract][Full Text] [Related]
8. The ubiquitous urushiols Contact dermatitis from mango, poison ivy, and other "poison" plants. 1968.
Goldstein N
Hawaii Med J; 2004 Aug; 63(8):231-5. PubMed ID: 15485071
[No Abstract] [Full Text] [Related]
9. Tacrolimus ointment 0.1% in the treatment of nickel-induced allergic contact dermatitis.
Saripalli YV; Gadzia JE; Belsito DV
J Am Acad Dermatol; 2003 Sep; 49(3):477-82. PubMed ID: 12963912
[TBL] [Abstract][Full Text] [Related]
10. Effect of a topical corticosteroid, a retinoid and a vitamin D3 derivative on sodium dodecyl sulphate induced skin irritation.
Le TK; De Mon P; Schalkwijk J; van der Valk PG
Contact Dermatitis; 1997 Jul; 37(1):19-26. PubMed ID: 9255481
[TBL] [Abstract][Full Text] [Related]
11. Allergic and irritant dermatitis: pathogenic and management aspects.
Marrakchi S
Recent Pat Inflamm Allergy Drug Discov; 2012 Sep; 6(3):167-8. PubMed ID: 22827836
[No Abstract] [Full Text] [Related]
12. Eyeglass frame allergic contact dermatitis: does tacrolimus prevent recurrences?
Nakada T; Iijima M; Maibach HI
Contact Dermatitis; 2005 Oct; 53(4):219-21. PubMed ID: 16191019
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory effect of pimecrolimus in the sodium lauryl sulphate test.
Engel K; Reuter J; Seiler C; Schulte Mönting J; Jakob T; Schempp CM
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):447-50. PubMed ID: 18031501
[TBL] [Abstract][Full Text] [Related]
14. Differential epidermal expression of the invariant chain in allergic and irritant contact dermatitis.
Emilson A; Lindberg M; Scheynius A
Acta Derm Venereol; 1998 Nov; 78(6):402-7. PubMed ID: 9833035
[TBL] [Abstract][Full Text] [Related]
15. Poison Ivy, Oak, and Sumac Dermatitis: What Is Known and What Is New?
Kim Y; Flamm A; ElSohly MA; Kaplan DH; Hage RJ; Hamann CP; Marks JG
Dermatitis; 2019; 30(3):183-190. PubMed ID: 31045932
[TBL] [Abstract][Full Text] [Related]
16. Topical tacrolimus 0.1% ointment (protopic) reverses nickel contact dermatitis elicited by allergen challenge to a similar degree to mometasone furoate 0.1% with greater suppression of late erythema.
Alomar A; Puig L; Gallardo CM; Valenzuela N
Contact Dermatitis; 2003 Oct; 49(4):185-8. PubMed ID: 14996065
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of SLS test.
Verberk MM
Contact Dermatitis; 2005 Apr; 52(4):235; author reply 236-7. PubMed ID: 15860003
[No Abstract] [Full Text] [Related]
18. Tacrolimus is not a preventive agent for occupational skin diseases.
Jungbauer F; Coenraads PJ
J Am Acad Dermatol; 2007 Mar; 56(3):519-20; author reply 520. PubMed ID: 17317492
[No Abstract] [Full Text] [Related]
19. Tacrolimus 0.1% ointment in the treatment of allergic contact dermatitis: a new approach.
Han JS; Won KH; Chang SE; Kim JE
Int J Dermatol; 2014 Oct; 53(10):e470-1. PubMed ID: 25070257
[No Abstract] [Full Text] [Related]
20. An open pilot study using tacrolimus ointment in the treatment of seborrheic dermatitis.
Meshkinpour A; Sun J; Weinstein G
J Am Acad Dermatol; 2003 Jul; 49(1):145-7. PubMed ID: 12833030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
